Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Synchronized electromechanical integration recording of cardiomyocytes.

Hu N, Wang T, Wan H, Zhuang L, Kettenhofen R, Zhang X, Zhang YS, Xu W, Gossmann M, Bohlen H, Hou X, Wang P.

Biosens Bioelectron. 2018 Oct 15;117:354-365. doi: 10.1016/j.bios.2018.06.017. Epub 2018 Jun 8.

PMID:
29940523
2.

Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation.

Rehnelt S, Malan D, Juhasz K, Wolters B, Doerr L, Beckler M, Kettenhofen R, Bohlen H, Bruegmann T, Sasse P.

Int J Mol Sci. 2017 Dec 6;18(12). pii: E2634. doi: 10.3390/ijms18122634.

3.

An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.

Koci B, Luerman G, Duenbostell A, Kettenhofen R, Bohlen H, Coyle L, Knight B, Ku W, Volberg W, Woska JR Jr, Brown MP.

Toxicol Appl Pharmacol. 2017 Aug 15;329:121-127. doi: 10.1016/j.taap.2017.05.023. Epub 2017 May 22.

PMID:
28546047
4.

[Progressive multifocal leukoencephalopathy following azathioprine and steroid treatment of pulmonary sarcoid disease].

Franzen D, Mathys C, Vesper J, Malzkorn B, Bohlen H, Seitz RJ.

Dtsch Med Wochenschr. 2015 Aug;140(17):1291-3. doi: 10.1055/s-0041-103278. Epub 2015 Aug 25. German.

PMID:
26306018
5.

Minimized cell usage for stem cell-derived and primary cells on an automated patch clamp system.

Becker N, Stoelzle S, Göpel S, Guinot D, Mumm P, Haarmann C, Malan D, Bohlen H, Kossolov E, Kettenhofen R, George M, Fertig N, Brüggemann A.

J Pharmacol Toxicol Methods. 2013 Jul-Aug;68(1):82-7. doi: 10.1016/j.vascn.2013.03.009. Epub 2013 Apr 6.

PMID:
23567076
6.

Differentiation and selection of hepatocyte precursors in suspension spheroid culture of transgenic murine embryonic stem cells.

Gabriel E, Schievenbusch S, Kolossov E, Hengstler JG, Rotshteyn T, Bohlen H, Nierhoff D, Hescheler J, Drobinskaya I.

PLoS One. 2012;7(9):e44912. doi: 10.1371/journal.pone.0044912. Epub 2012 Sep 24.

7.

Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment.

Abassi YA, Xi B, Li N, Ouyang W, Seiler A, Watzele M, Kettenhofen R, Bohlen H, Ehlich A, Kolossov E, Wang X, Xu X.

Br J Pharmacol. 2012 Mar;165(5):1424-41. doi: 10.1111/j.1476-5381.2011.01623.x.

8.

Automated patch clamp on mESC-derived cardiomyocytes for cardiotoxicity prediction.

Stoelzle S, Haythornthwaite A, Kettenhofen R, Kolossov E, Bohlen H, George M, Brüggemann A, Fertig N.

J Biomol Screen. 2011 Sep;16(8):910-6. doi: 10.1177/1087057111413924. Epub 2011 Jul 20.

PMID:
21775699
9.

Response to "The microEST in vitro test for embryotoxicity - a case of mistaken identity?" by Robert Combes.

Schwengberg S, Bohlen H, Fronhoff B.

Toxicol In Vitro. 2009 Mar;23(2):362-3. doi: 10.1016/j.tiv.2008.11.013. Epub 2008 Dec 10. No abstract available.

PMID:
19111605
10.

Preclinical assessment of cardiac toxicity.

Kettenhofen R, Bohlen H.

Drug Discov Today. 2008 Aug;13(15-16):702-7. doi: 10.1016/j.drudis.2008.06.011. Epub 2008 Jul 24. Review.

PMID:
18602016
11.

Scalable selection of hepatocyte- and hepatocyte precursor-like cells from culture of differentiating transgenically modified murine embryonic stem cells.

Drobinskaya I, Linn T, Saric T, Bretzel RG, Bohlen H, Hescheler J, Kolossov E.

Stem Cells. 2008 Sep;26(9):2245-56. doi: 10.1634/stemcells.2008-0387. Epub 2008 Jun 12.

12.

Potential risks of bone marrow cell transplantation into infarcted hearts.

Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM, Fries JW, Tiemann K, Bohlen H, Hescheler J, Welz A, Bloch W, Jacobsen SE, Fleischmann BK.

Blood. 2007 Aug 15;110(4):1362-9. Epub 2007 May 4.

13.

Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium.

Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren JM, Sasse P, Rubenchik O, Fries JW, Wenzel D, Geisen C, Xia Y, Lu Z, Duan Y, Kettenhofen R, Jovinge S, Bloch W, Bohlen H, Welz A, Hescheler J, Jacobsen SE, Fleischmann BK.

J Exp Med. 2006 Oct 2;203(10):2315-27. Epub 2006 Sep 5.

14.

Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer.

Weihrauch MR, Ansén S, Jurkiewicz E, Geisen C, Xia Z, Anderson KS, Gracien E, Schmidt M, Wittig B, Diehl V, Wolf J, Bohlen H, Nadler LM.

Clin Cancer Res. 2005 Aug 15;11(16):5993-6001.

15.

Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.

Weihrauch MR, Manzke O, Beyer M, Haverkamp H, Diehl V, Bohlen H, Wolf J, Schultze JL.

Cancer Res. 2005 Jul 1;65(13):5516-9.

16.

Determination of electrical properties of ES cell-derived cardiomyocytes using MEAs.

Hescheler J, Halbach M, Egert U, Lu ZJ, Bohlen H, Fleischmann BK, Reppel M.

J Electrocardiol. 2004;37 Suppl:110-6. Review.

PMID:
15534819
17.

Immunomagnetic enrichment and detection of isolated tumor cells in bone marrow of patients with epithelial malignancies.

Weihrauch MR, Skibowski E, Draube A, Geller A, Tesch H, Diehl V, Bohlen H.

Clin Exp Metastasis. 2002;19(7):617-21.

PMID:
12498391
18.

Immunomagnetic enrichment and detection of micrometastases in colorectal cancer: correlation with established clinical parameters.

Weihrauch MR, Skibowski E, Koslowsky TC, Voiss W, Re D, Kuhn-Regnier F, Bannwarth C, Siedek M, Diehl V, Bohlen H.

J Clin Oncol. 2002 Nov 1;20(21):4338-43.

PMID:
12409333
19.

Influence of genomics on cancer vaccine development from guess to prediction.

Schultze JL, Bohlen H.

Curr Pharm Des. 2002;8(19):1735-48. Review.

PMID:
12171545
20.

Cellular cardiomyoplasty improves survival after myocardial injury.

Roell W, Lu ZJ, Bloch W, Siedner S, Tiemann K, Xia Y, Stoecker E, Fleischmann M, Bohlen H, Stehle R, Kolossov E, Brem G, Addicks K, Pfitzer G, Welz A, Hescheler J, Fleischmann BK.

Circulation. 2002 May 21;105(20):2435-41.

PMID:
12021233

Supplemental Content

Loading ...
Support Center